These observations indicate that hepatocytic Smad3 phospho-isoform signaling can shift from tumor-suppressive pSmad3C signaling to carcinogenic pSmad3L signaling during the progression of chronic liver disease. This evidence concerns the gene SMAD3 and neoplasm.